149 related articles for article (PubMed ID: 1757609)
21. Halobetasol Propionate Lotion, 0.05% Provides Superior Hydration Compared to Halobetasol Propionate Cream, 0.05% in a Double-Blinded Study of Occlusivity and Hydration.
Grove G; Zerweck C; Houser T; Andrasfay A; Gauthier B; Holland C; Piacquadio D
J Drugs Dermatol; 2017 Feb; 16(2):140-144. PubMed ID: 28300856
[TBL] [Abstract][Full Text] [Related]
22. Diflucortolone valerate. Asian experience.
Hoppe G
Drugs; 1988; 36 Suppl 5():24-33. PubMed ID: 3254827
[TBL] [Abstract][Full Text] [Related]
23. Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis.
Salmhofer W; Maier H; Soyer HP; Hönigsmann H; Hödl S
Acta Derm Venereol Suppl (Stockh); 2000; (211):5-8. PubMed ID: 11234559
[TBL] [Abstract][Full Text] [Related]
24. [Results of a multicenter double-blind study in patients with resistant psoriasis and atopic dermatitis. Diprolene ointment vs. Dermovate ointment].
Blum G; Kröpfli P; Küng D; Suter H
Ther Umsch; 1984 Jun; 41(6):420-4. PubMed ID: 6379974
[No Abstract] [Full Text] [Related]
25. Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement.
Lebwohl M; Yoles A; Lombardi K; Lou W
J Am Acad Dermatol; 1998 Sep; 39(3):447-50. PubMed ID: 9738781
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of hydrocortisone valerate 0.2% ointment.
Sefton J; Loder JS; Kyriakopoulos AA
Clin Ther; 1984; 6(3):282-93. PubMed ID: 6373007
[TBL] [Abstract][Full Text] [Related]
27. Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial.
Corrocher G; Di Lorenzo G; Mansueto P; Martinelli N; Esposito-Pellitteri M; Gelio S; Lombardo G; Pacor ML
Clin Ther; 2006 Sep; 28(9):1296-302. PubMed ID: 17062302
[TBL] [Abstract][Full Text] [Related]
28. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part I: Comparative study of diflucortolone valerate with fluocortolone, -capronate, -pivalate in a double-blind contralateral design with topical application (author's transl)].
Reckers VR; Wendt H
Arzneimittelforschung; 1976; 26(7b):1499-504. PubMed ID: 795433
[TBL] [Abstract][Full Text] [Related]
29. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH
Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
[TBL] [Abstract][Full Text] [Related]
30. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
31. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.
Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V
J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289
[TBL] [Abstract][Full Text] [Related]
32. Clobetasol propionate ointment 0.05% versus diflorasone diacetate ointment 0.05% in moderate to severe psoriasis.
Jegasothy BV
Int J Dermatol; 1990 Dec; 29(10):729-30. PubMed ID: 2269571
[No Abstract] [Full Text] [Related]
33. A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis.
Kerdel FA; Draelos ZD; Tyring SK; Lin T; Pillai R
J Dermatolog Treat; 2019 Jun; 30(4):333-339. PubMed ID: 30207807
[No Abstract] [Full Text] [Related]
34. [Topical treatment of dermatoses with difluocortolone valerate fatty ointment].
Carvajal Rosado VM
Z Hautkr; 1976; 51 Suppl 1():27-9. PubMed ID: 795183
[TBL] [Abstract][Full Text] [Related]
35. [Use of 0.3% diflucortolone valerate in the topical treatment of steroid-sensitive dermatitis].
Jucci A; Fideli D; Speziali A
G Ital Dermatol Venereol; 1986; 121(6):LXXVII-LXXX. PubMed ID: 3549546
[No Abstract] [Full Text] [Related]
36. [Biologic availability of diflucortolone-21-valerate in human skin].
Täuber U
Arzneimittelforschung; 1983; 33(10):1503-7. PubMed ID: 6686053
[TBL] [Abstract][Full Text] [Related]
37. Clobetasone butyrate compared with betamethasone valerate in the treatment of atopic and contact dermatitis.
Fredriksson T; Nordin K
Curr Med Res Opin; 1979; 6(5):322-4. PubMed ID: 540522
[TBL] [Abstract][Full Text] [Related]
38. Comparative efficacy of tacrolimus 0.1% ointment and clobetasol propionate 0.05% ointment in oral lichen planus: a randomized double-blind trial.
Sonthalia S; Singal A
Int J Dermatol; 2012 Nov; 51(11):1371-8. PubMed ID: 23067089
[TBL] [Abstract][Full Text] [Related]
39. [Topical treatment of various dermatosis with difluocortolone valerianate. (ointment) Double blind comparative study].
Cavajal Rosado VM
Prensa Med Mex; 1976; 41(5-6):183-5. PubMed ID: 792865
[TBL] [Abstract][Full Text] [Related]
40. A controlled trial of clobetasol propionate ointment 0.05% in the treatment of experimentally induced Rhus dermatitis.
Vernon HJ; Olsen EA
J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):829-32. PubMed ID: 2147698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
